Page last updated: 2024-10-31

neostigmine and Dysesthesia

neostigmine has been researched along with Dysesthesia in 2 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahasan, HA1
Al Mamun, A1
Rasul, CH1
Roy, PK1
Mercadante, S1
Serretta, R1
Sapio, M1
Villari, P1
Calderone, L1

Other Studies

2 other studies available for neostigmine and Dysesthesia

ArticleYear
Puffer fish poisoning (tetrodotoxin) in Bangladesh: clinical profile and role of anticholinesterase drugs.
    Tropical doctor, 2005, Volume: 35, Issue:4

    Topics: Animals; Bangladesh; Cholinesterase Inhibitors; Female; Fishes, Poisonous; Foodborne Diseases; Human

2005
When all else fails: stepwise multiple solutions for a complex cancer pain syndrome.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1999, Volume: 7, Issue:1

    Topics: Aged; Analgesics; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; Cholinesterase Inhibitors; Cl

1999